• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2, Colombia

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2020 Dec;26(12):2854-2862.
doi: 10.3201/eid2612.202969.
Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2, Colombia

Katherine Laiton-Donato, Christian Juli?n Villabona-Arenas, Jos? A Usme-Ciro, Carlos Franco-Mu?oz, Diego A ?lvarez-D?az, Liz Stephany Villabona-Arenas, Susy Echeverr?a-Londo?o, Zulma M Cucunub?, Nicol?s D Franco-Sierra, Astrid C Fl?rez, Carolina Ferro, Nadim J Ajami, Diana Marcela Walteros, Franklin Prieto, Carlos Andr?s Dur?n, Martha Lucia Ospina-Mart?nez, Marcela Mercado-Reyes

Abstract

Coronavirus disease (COVID-19) in Colombia was first diagnosed in a traveler arriving from Italy on February 26, 2020. However, limited data are available on the origins and number of introductions of COVID-19 into the country. We sequenced the causative agent of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from 43 clinical samples we collected, along with another 79 genome sequences available from Colombia. We investigated the emergence and importation routes for SARS-CoV-2 into Colombia by using epidemiologic, historical air travel, and phylogenetic observations. Our study provides evidence of multiple introductions, mostly from Europe, and documents >12 lineages. Phylogenetic findings validate the lineage diversity, support multiple importation events, and demonstrate the evolutionary relationship of epidemiologically linked transmission chains. Our results reconstruct the early evolutionary history of SARS-CoV-2 in Colombia and highlight the advantages of genome sequencing to complement COVID-19 outbreak investigations.

Keywords: COVID-19; Colombia; SARS; SARS-CoV-2; coronavirus; coronavirus disease; genome sequencing; phylogenomics; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
 
Back
Top Bottom